Apart from manufacturing products for direct sales, the company also manufactures various pharmaceutical products for different marketers on a loan license or contract manufacturing basis.
Additionally, the company plans to use ₹99.17 lakhs for repayment or prepayment of certain borrowings availed by the company and ₹14.68 crore for funding working capital requirements.
According to the red herring prospectus (RHP), the three-day subscription window will tentatively close on Friday, May 16, 2025. The anchor investor bid period shall be one working day prior to the issue opening date i.e, Tuesday, May 13, 2025.
The story "Accretion Pharmaceuticals IPO opens on May 14: Here's all you need to know" has 542 words across 27 sentences, which will take approximately 3 - 5 minutes for the average person to read.
Which news outlet covered this story?
The story "Accretion Pharmaceuticals IPO opens on May 14: Here's all you need to know" was covered 13 hours ago by Business Standard, a news publisher based in India.
How trustworthy is 'Business Standard' news outlet?
Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.
The outlet is headquartered in India and publishes an average of 290 news stories per day.
It's most recent story was published 2 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
